Asensus Surgical, Inc. (ASXC) Price Chart

The price history of Asensus Surgical, Inc. (ASXC) on the GURU.Markets platform reflects the dynamics of a company developing AI tools and surgical robotics, where the indicator stands at 0.35. Anthony Fernando is implementing digital laparoscopy systems aimed at optimizing surgical outcomes. To smooth out profits from one-off equipment sales, the business is developing a network of service subscriptions. Meanwhile, the production of standard electronics has been outsourced to contractors, while navigation development remains an in-house operation.

Asensus Surgical, Inc. - ASXC Share Price (period 07/04/2022 - 08/31/2024)

Comprehensive metric breakdowns and analytics for TransEnterix (ASXC)

- stock quotes and analyst forecast:

Stock Price Asensus Surgical, Inc.|ASXC - Analyst Consensus Forecast

- market capitalization details:

Market Value Asensus Surgical Inc|ASXC - Company Buyout Price

- balance sheet equity data:

Accounting Value per Share Asensus Surgical|ASXC - Accounting Capitalization|Market Capitalization to Book Value Ratio asensus.com|ASXC - Cumulative Company Assets

- debt and liquidity details:

- financial results and valuation multiples details:

ASXC - Net Profit|Expected Profit Asensus Surgical, Inc.|ASXC - Market Cap to Net Income|Forward P/E Multiple Asensus Surgical, Inc.|ASXC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Asensus Surgical Inc|ASXC - Operating profit EBITDA|Net earnings per share for the last 12 months Asensus Surgical|ASXC - Earnings per share for the last four quarters|Quarterly EPS earnings growth asensus.com|ASXC - Expected net earnings per share growth this year|Earnings growth forecast for next year Asensus Surgical, Inc.

Fundamental valuation:Asensus Surgical

For Asensus Surgical, Inc. (ASXC), the market value reflects an objective balance of supply and demand, capturing actual transactions while filtering out market noise. Analysis of this market value chart allows for an assessment of the degree of asset discounting amid an acute liquidity shortage and the slow adoption of the Senhance system, which is critical for determining an entry point given the high bankruptcy risks.

Competitors of Asensus Surgical, Inc. (ASXC)